Greenville, DE, United States of America

Ge Zou

USPTO Granted Patents = 7 


Average Co-Inventor Count = 4.4

ph-index = 5

Forward Citations = 63(Granted Patents)


Location History:

  • Wilmington, DE (US) (2017)
  • Greenville, DE (US) (2018 - 2023)

Company Filing History:


Years Active: 2017-2023

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Ge Zou: Innovator in Pharmaceutical Chemistry

Introduction

Ge Zou is a prominent inventor based in Greenville, Delaware, known for his significant contributions to pharmaceutical chemistry. With a total of seven patents to his name, he has made remarkable strides in the development of compounds that target critical health issues.

Latest Patents

Among his latest patents are innovative heterocyclic compounds that serve as inhibitors of PI3K-γ. These compounds are designed to treat a variety of disorders, including autoimmune diseases, cancer, cardiovascular diseases, and neurodegenerative diseases. The applications focus on compounds of Formula (I) or their pharmaceutically acceptable salts or stereoisomers, showcasing his commitment to advancing medical science.

Career Highlights

Ge Zou is currently employed at Incyte Corporation, a leading biopharmaceutical company. His work at Incyte has positioned him at the forefront of research and development in the pharmaceutical industry, where he continues to explore new therapeutic avenues.

Collaborations

Throughout his career, Ge Zou has collaborated with notable colleagues, including Andrew Paul Combs and Andrew W. Buesking. These partnerships have fostered a collaborative environment that enhances innovation and accelerates the development of new treatments.

Conclusion

Ge Zou's contributions to pharmaceutical chemistry and his innovative patents reflect his dedication to improving healthcare outcomes. His work continues to inspire advancements in the treatment of complex diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…